CMHC Exhibitor Showcase

Otsuka America Pharmaceutical, Inc. (OAPI), part of the Otsuka Group, is responsible for commercial activities in the U.S., focusing on a diverse portfolio of products in neuroscience, oncology and cardio-renal.

OAPI has a solid track record in commercializing products developed by Otsuka, as well as in-licensed products, over the last 25 years. The future looks even more exciting, with numerous new products under development at our sister company, Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC). Recent alliances with other pharma companies, as well as strategic acquisitions by the Otsuka Group, may further enhance our ability to offer new products to customers and, ultimately, millions of patients with unmet medical needs.